B
one is the second most transplanted tissue after blood. 1 It is estimated that more than 500,000 bone-grafting procedures are performed annually in the United States and 2.2 million worldwide. 2 Autogenous bone grafts continue to be considered the ''gold standard'' in reconstructive surgery due to their ability to regenerate new bone. Despite this, autogenous bone has many shortcomings, including the need for a second surgery to harvest the graft, donor site morbidity, irregular resorption of transplanted bone, and limited availability of donor bone.
1Y3 These limitations have led to extensive research and the further development of synthetic biomaterials.
Synthetic materials are relatively abundant, easy to manufacture, and eliminate many of the major problems associated with autogenous grafts. Calcium phosphate compounds have been studied extensively over that last decade due to their close resemblance to the body's hard tissue mineral component and their excellent biocompatibility. 4, 5 The most widely investigated calcium phosphates are hydroxyapatite (HA) and b-tricalcium phosphate (b-TCP). 6, 7 These biomaterials have no immunologic reaction or systemic toxicity. At physiological pH, From the Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
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resorption rate of b-TCP is faster than HA, making b-TCP mechanically weaker, 8 but has the advantage of not remaining in the repair site for extended periods. Mixing HA and b-TCP forms biphasic calcium phosphates (BCP). The ratio of HA and b-TCP can be varied to alter the rate of degradation of the BCP. 9 The gradual degradation of BCP at the implant site releases calcium and phosphorus ions into the biological environment, creating a favorable medium for new bone formation. 10 The ideal bioimplant for bone tissue repair should be biocompatible, osteoconductive, osteoinductive, and biodegradable. 4, 10 Osteoinduction refers to the ability to stimulate mesenchymal cells, even in a nonosseous environment, to differentiate into osteoblasts. 6, 11 The capacity of a biomaterial to be osteoinductive has been shown to be a direct result of the presence of bone morphogenetic proteins (BMP) within its substance, 12, 13 and it has been shown that BMPs can be combined with calcium phosphates to enhance bone healing. 6, 11, 14, 15 Pluronic F-127 (Pluronic, BASF, Mt. Olive, NJ) is an inert polymer; stable to acid, alkali, and metal ions, and has been listed as an inactive ingredient by the FDA. 16, 17 No toxic reactions have been noted in both acute and chronic exposure to Pluronic. Pluronic may be formulated to increase in viscosity as the temperature rises above 4-C and form into a moldable gel once present above room temperature. 16 Pluronic has been combined with demineralized bone matrix to enhance handling, moldability, graft retention, and delivery by injection. 3 The purpose of this investigation was to assess the ability of two types of synthetic calcium phosphates, 100% HA (C-Graft,i Citagenix Inc, Laval, Canada) and biphasic calcium phosphate (80/20 HA/b-TCP; Algisorb,i Citagenix Inc, Laval, Canada), to support the healing of criticallysized cranial vault defects in combination with Pluronic and/or BMP.
MATERIALS AND METHODS

C
-Grafti (100% HA) and the Algisorbi (BCP), were both provided by Citagenix Inc. (Laval, Canada). These bioimplants were in granular form ranging in size from 300 to 1,000 microns. The carrier Pluronic was prepared as previously described. 15 The BMP used for this investigation was OP-1\ (Stryker Biotech Inc., Hopkinton, MA).
Experimental Design
Twenty-five skeletally mature New Zealand White male rabbits (Charles River Laboratories, Montreal, QC, Canada) weighing 3.5 to 4.0 kg were randomly divided into groups of 5 animals each. Two 15 mm diameter critically-sized defects were made in the parietal bones of each rabbit. All of the animals were euthanized at 6 weeks.
Surgical Protocol
The surgical procedures for this investigation were performed according to recognized techniques approved by the University of Toronto, Animal Care Ethics Committee (NO. 20005030). Each animal was premedicated according to their weight with a composite of acepramazine (1 mg/kg), ketamine (35 mg/kg), and zylazine (2 mg/kg). General anesthesia was induced using intravenous sodium thiopental (20 mg/kg). After induction, a 3 mm uncuffed endotracheal tube was used for intubation. Anesthesia was maintained with 1:1.5% insoflurane and oxygen composite using mechanical ventilation. The animals were monitored using pulse oxymetry. Respiration rate of the animal was set at 20 breaths per minute with a tidal volume of 10 mL/kg.
An incision was made along the midline of the scalp from a point midway between the base of the ears to approximately 5 cm anteriorly through fullthickness skin. Sharp subperiosteal dissection reflected the pericranium from the outer table of the cranial vault exposing the parietal bones. An electric drill with a 702 fissure bur under copious saline irrigation was used to create bilateral fullthickness calvarial defects. The defects were ovoid in shape measuring 15 mm by 13 to 15 mm. A surgical template was used to define the defect margins. Two defects were created, one on each side of the midline. The bioimplants were placed directly to fill the defects (Fig 1) . Care was taken to prevent displacement of the test materials into other defect (cross contamination). The pericranium and skin were closed with resorbable sutures.
Test Groups
Group 1: Autogenous vs. Unfilled
In Group 1 (n = 5), each animal had one defect left unfilled to serve as the control. These defects were allowed to heal spontaneously. The contralateral defects were filled with morcelized autogenous bone, which was the bone removed from the calvaria. 
Histology
All animals were euthanized at 6 weeks. The cranial vault was carefully removed from each animal. The calvaria specimens were placed in 10% neutral buffered formalin for 72 hours, decalcified in formic acid, and embedded in paraffin. Multiple 6 mm sections were cut from the middle of each specimen and stained with hematoxylin-eosin (H and E) for quantification of the amount of bone regeneration under light microscopy. 
Histomorphometry
Histomorphometric analysis was performed first by viewing the H and E stained sections under a light microscope (Leitz, Wetzlar, Germany) at Â1.25 magnification. The sagittal suture was used as a landmark to identify the site of defects. Multiple serial pictures of specimens were captured using an RT Color digital camera (Diagnostic Instruments Inc., Sterling Heights, MI) attached to the microscope and displayed on the computer monitor. The serial pictures were then merged into one image using Adobe Photoshop Element 2.0 (Adobe Systems Inc., San Jose, CA) software. The merged images were calibrated and quantified.
The areas of total defect, new bone, bone marrow space, residual biomaterial, and soft tissue were measured from the merged images using Image Pro\ Plus 4.3 software (Media Cybernetics, Carlsbad, CA). These measurements were made on five histology slides for each animal. Measurement data were exported to Microsoft Excel once compiled. Measurements were expressed as a percentage of the total defect area. 
Statistical Analysis
Histomorphometric results were analyzed using SigmaStat\ 3.0 (Systat Inc. Point Richmond, CA) statistical software. Comparison of contralateral treatments within the same group was done by paired T-tests. One-way ANOVA or Two-way ANOVA was performed to evaluate for statistical significance between the various groups and the SNK post hoc test was used to determine which groups were significantly different. Statistical significance was established at P G 0.05.
RESULTS
A ll animals survived the surgical procedure and were available for analysis. Gross examination at necropsy showed no signs of inflammatory reaction in any of the defects.
Histological Evaluation
Unfilled Defects
At 6 week, fibrous tissue filled most of the defect (Fig 2) . Healing of the defects was mainly by scar formation. Bony ingrowth was visible at margins of the defects. Some defects had a few bony islands close to the dural lining.
Autogenous Bone
Histological analysis demonstrated complete union across all defects making the defect margins indistinguishable. These defects were filled with the implanted autogenous bone and newly-formed woven bone (Fig 3) . New bone contained marrow spaces which were highly cellular (Fig 3A) . Large numbers of red blood cells (RBCs) were visible, indicating vascularization (Fig 3B) . The pericranial contour appeared convex due to increased bone height.
C-Graft-Filled Defects
Histological examination revealed complete bony union across all defects. Integration of new bone to the presurgical bone occurred at the defect margins. New bone formation was observed, which was distinguished by its more intense staining (Fig 4) . The height of regenerated bone was slightly thinner at the centre of the defect, mostly on the brain side. C-Grafti granules appeared complete with little sign ofdegradation and resorption (Fig 4B) . Little or no bony in growth was observed within the granules.
C-Graft + Pluronic
Defects filled with G-Grafti + Pluronic appeared indistinguishable from the defects filled with CGrafti by histological evaluation (Figs 5 and 6 ).
C-Graft + Pluronic + BMP
Histologically, C-Grafti + Pluronic + BMP-filled defects demonstrated bone growth across the entire defect (Fig 7) . The amount of new bone and marrow space was greater than that of C-Grafti filled or CGrafti + Pluronic filled defects (Fig 8) . There was little evidence of C-Grafti degradation, as the granules appeared complete and had not lost their original morphology.
Algisorb
Histological examination revealed that Algisorb was able to conduct new bone formation. Integration of new bone to the presurgical bone occurred at the defect margins. There was minimal amount of bony in growth into the Algisorb granules. Algisorb granules demonstrated some degradation as its granules appeared less compact and had voids within them and bone was observed within the body of the granules (Fig 9) . 
Algisorb + Pluronic
Defects filled with Algisorb appeared indistinguishable from the defects filled with Algisorb + Pluronic by histological evaluation (Figs 10 and 11 ).
Algisorb + BMP
Histologically, defects had complete bony union. A desirable thickness was achieved for all the defects, making them comparable to the defects filled with autogenous bones. Defects filled with Algisorb + BMP had greater amount of new bone formation and marrow spaces than defects treated without Algisorb alone or Algisorb + Pluronic (Fig 12) . There were increased numbers of voids around the Algisorb granules, which might have been a result of rapid degradation of the b-TCP.
Algisorb + BMP + Pluronic
Defects filled with Algisorb + BMP + Pluronic were indistinguishable histologically from Algisorb + BMP-filled defects (Figs 13 and 14) .
Histomorphometric Analysis
Histomorphometry results are summarized in Tables  1 and 2 . After 6 weeks, the autogenous-filled defects demonstrated a significantly higher volume of bone and marrow (reparative tissue) than the control (unfilled defects) (P G 0.001).
In the groups treated using C-Graft (groups 2 and 3), C-Graft-filled and C-Graft + Pluronic-filled defects demonstrated similar amounts of new bone and marrow. The defects reconstructed using C-Graft + Pluronic + BMP contained significantly greater volume of reparative tissue compared to defects filled with C-Graft + Pluronic alone (P = 0.007).
In the groups with Algisorb (groups 4 and 5), Algisorb-filled and Algisorb + Pluronic-filled defects demonstrated similar volume of new bone and marrow. The amount of reparative tissue was significantly higher when BMP was added to Algisorb. Algisorb + BMP-filled and Algisorb + BMP + Pluronic-filled defects demonstrated desirable volume of reparative tissue, almost reaching the amount formed by defect filled with autogenous bones. While no differences were seen in the amount of reparative tissue when Pluronic was added to Algisorb, there was slightly more reparative tissue in grafts containing Algisorb + BMP compared to those containing Algisorb + BMP + Pluronic (P = 0.048).
By ANOVA, addition of Pluronic to C-Grafti and Algisorb did not demonstrate statistical significance on the percentage of reparative tissue regenerated (P = 0.355 and P = 0.876, respectively). However, the addition of BMP to C-Grafti and Algisorb considerably increased the amount of new bone compared to void-filled defects (P = 0.003 and P = 0.006, respectively). Within the limits of this investigation, we were unable to demonstrate significant difference in the healing that resulted from using C-Grafti and Algisorb.
DISCUSSION
T he repair and reconstruction of critically-sized calvarial defects remains a significant clinical challenge. Current techniques for calvarial defect reconstruction rely heavily on autogenous bone, which can be difficult to contour and undergoes significant and unpredictable resorption. The use of autogenous bone also has significant complications associated with donor site morbidity, limited amounts of donor tissue and extended time in surgery. 19 Consequently, researchers are working to develop biocompatible, osteoconductive, osteoinductive, and moldable bioimplants that may eventually replace the need for harvesting autogenous bone.
Both synthetic biomaterials used in this study, C-Grafti (100% HA) and Algisorb (BCP; HA/b-TCP ratio of 80/20), are calcium phosphates. To enhance handling and moldability they were used combination with Pluronic F-127, while bone morphogenetic protein (BMP) was used to provide osteoinductive activity. The use of calcium phosphate compounds in combination with BMP and Pluronic provided a series of unique bioimplants for this investigation.
C-Graft and Algisorb demonstrated similar bone repair at 6 weeks. There was no significant difference between the amounts of new bone, marrow space, and soft tissue. Slight degradation of BCP granules was observed histologically while none was seen for HA as was expected since the degradation of b-TCP is more rapid than HA. However, due to the small amount of b-TCP (20%) in Algisorb, the integrity and degradation of the implant was not significantly affected.
Other research groups have demonstrated that BCP implants achieve a better performance than pure HA implants. Kruyt et al 20 tested BCP and HA scaffolds in an ovine spinal cassette model and demonstrated the BCP scaffolds (HA/TCP ratio of 80/20) appeared to be more osteoconductive. Yuan 21 showed similar results in a canine femoral model: defects filled with BCP (40% b-TCP) had earlier bone formation and large amount of bone than HA filled defects. Researchers suggested that BCP granules degrade faster than pure HA, thus provide space for bone ingrowth. 20Y22 In our study, we were unable to demonstrate any difference in the amount of new bone formation or residual biomaterial between BCP and HA. However, BCP implants gave the impression of having more bone within the body of the biomaterial granules.
Pluronic F-127 is a temperature sensitive polymer, which when dissolved in water it is liquid at low temperature, but gels at room temperature. However, once it is cooled down again it returns to is liquid form. As a gel Pluronic can act to bind the calcium phosphate granules together, allowing the bioimplant to become moldable, permitting easy shaping while preventing migration of granules out of the site due to bleeding or tissue closure. Combining Pluronic with either implant material improved ease of handling during surgery and enhanced the surgeon's ability to mold and shape the graft. Further, no sign of displacement of the granules due to bleeding or during closure was observed.
At 6 weeks, no distinguishable histological differences were seen in the healing of defects filled with implants containing the calcium phosphates in combination with Pluronic compared to the calcium phosphates alone. These findings were supported by the results from histomorphometric analysis. This suggested that similar amounts of new bone formed in the defects with or without Pluronic. Thus, the addition of Pluronic did not impede osteoconduction along the biomaterials or affect their ability to promote healing.
The positive effect of BMP on bone regeneration is evident from this study. At 6 weeks, greater amounts of new bone and bone marrow spaces were observed histologically. This was supported by histomorphometry results, which demonstrated the incorporation of BMP into the bioimplants induced a 33.8% increase in reparative tissue formation (bone + bone marrow) compared to those defects without BMP. The amount of new bone regenerated was comparable to those defects filled autogenous bone, the accepted gold standard. This result supported the hypothesis that BMP is capable of inducing new bone and marrow formation and improves the performance of the calcium phosphates. BMP is integral in the regulation of embryologic bone formation and posttraumatic bone healing/ formation. 6 Researchers have previously demonstrated that BMP can cause bone formation in vivo if present in sufficient quantity. 6, 7, 23 In a study conducted by Haddad et al 7 using a rabbit calvarial model, it was found that at 6 weeks the addition of BMP to calcium phosphate cement (CPC) increased reparative formation by 11.8%. At 12 weeks, defects filled with CPC and BMP had a 32.8% increase in reparative tissue compared to the defects filled with no BMP. These results are consistent with our findings that BMP induces the formation of new bone and bone marrow. It also suggests that if the period of investigation were extended (e.g. 12 weeks), greater amounts of new bone and reparative tissue can be expected. The difference identified in the amount of reparative tissue seen in this study as compared to that of Haddad et al 7 (33.8% and 11.8%, respectively) can be explained by the difference in BMP dosage and biomaterials used for each study. In this investigation, 70 mg of BMP per cc of bioimplant (particulate HA or BCP) was used, whereas Haddad et al 7 used 25 mg of BMP per cc of bioimplant.
The results of this investigation suggest that there is little difference between C-Graft and Algisorb in their respective abilities to support bone healing in this model at this time. Furthermore, the addition of Pluronic improved the ability to handle and shape these materials without compromising their ability to promote bone healing. The addition of BMP to these bioimplants significantly increased their ability for reparative tissue regeneration in this model as reflected by significant increases in the amounts of new bone and bone marrow.
Finally, the combination of BMP and Pluronic with either C-Graft or Algisorb demonstrated a superior ability to successfully support the repair of critical-sized defects in rabbits at 6 weeks. The combination of these biomaterials with BMP and Pluronic F-127 may prove to be useful clinically for the repair craniofacial defects and eventually obviate the need for autogenous bone harvesting. The P value was calculated using the paired t-test.
Results represent the percentage of the defect filled with residual biomaterial, and are presented as mean T SD.
